Showing results (81-90 of 111) with videos related to

Sort By:
Pageof 12
Mabs|October 27, 2015
Influence of molecular size on tissue distribution of antibody fragmentsZhe Li, Ben-Fillippo Krippendorff, Sharad Sharma, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|August 8, 2019
Effect of Size on Solid Tumor Disposition of Protein TherapeuticsZhe Li, Yingyi Li, Hsuan-Ping Chang, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 24, 2009
Use of an anti-vascular endothelial growth factor antibody in a pharmacokinetic strategy to increase the efficacy of intraperitoneal chemotherapyDhaval K Shah, Beom Soo Shin, Jean Veith, et al.
Oncoscience|October 15, 2019
In situ analysis of Her2 DNA and RNA in retinoblastoma and adjacent retinaGail M Seigel, Dhaval K Shah, Pia Mendoza, et al.
The AAPS Journal|January 16, 2020
Antibody Coadministration as a Strategy to Overcome Binding-Site Barrier for ADCs: a Quantitative InvestigationAman P Singh, Leiming Guo, Ashwni Verma, et al.
Mabs|January 27, 2021
Brain pharmacokinetics of anti-transferrin receptor antibody affinity variants in rats determined using microdialysisHsueh-Yuan Chang, Shengjia Wu, Yingyi Li, et al.
Neuro-Oncology Advances|October 28, 2024
A phase 1 dose escalation of pritumumab in patients with refractory or recurrent gliomas or brain metastasesJose Carrillo, Jaya Mini Gill, Charles Redfern, et al.
Current Opinion in Toxicology|January 9, 2018
Quantitative systems toxicologyPeter Bloomingdale, Conrad Housand, Joshua F Apgar, et al.
The AAPS Journal|November 9, 2021
Pharmacokinetics of Monoclonal Antibody and Antibody Fragments in the Mouse Eye Following Systemic AdministrationDavid Bussing, Zhe Li, Yingyi Li, et al.
British Journal of Clinical Pharmacology|June 30, 2021
A population physiologically-based pharmacokinetic model to characterize antibody disposition in pediatrics and evaluation of the model using infliximabHsuan Ping Chang, Valentina Shakhnovich, Adam Frymoyer, et al.
Pageof 12